TickerFacts.

REGENXBIO Inc. (RGNX): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$49.76M
Year ended 2024-12-31
-50.8%
3-year compound annual growth
+13.0%
5-year compound annual growth
$418.51M2017-12-31: $8.68M2019-12-31: $26.99M2020-12-31: $118.85M2021-12-31: $418.51M2022-12-31: $58.18M2023-12-31: $53.03M2024-12-31: $49.76M$49.76M
2017-12-31 Gross Profit (USD) 2024-12-31
Period endedGross ProfitChange YoYSource filing
2024-12-31$49.76M-6.2%2026-03-05, From 2024-01-01
2023-12-31$53.03M-8.9%2025-03-13, From 2023-01-01
2022-12-31$58.18M-86.1%2025-03-13, From 2022-01-01
2021-12-31$418.51M+252.1%2024-02-27, From 2021-01-01
2020-12-31$118.85M+340.3%2023-02-28, From 2020-01-01
2019-12-31$26.99Mn/a2022-03-01, From 2019-01-01
No annual figure between 2017-12-31 and 2019-12-31.
2017-12-31$8.68Mn/a2020-02-26, From 2017-01-01